The “Cherry” Release of O-RAN Open Software Moves the O-RAN Ecosystem Closer to Deployment in Mobile Networks Around the Globe
11.1.2021 19:51:00 EET | Business Wire | Press release
In December 2020, the O-RAN Software Community (OSC), working with the Linux Foundation, published its 3rd open software release within 18 months, dubbed “Cherry”.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210111005829/en/
O-RAN Logical Architecture (Graphic: Business Wire)
Cherry moves the O-RAN ecosystem closer to commercial deployments in mobile networks around the globe. On top of new functions aligned with the latest O-RAN specifications, such as the E2, A1 and O1 interfaces, this release also features significant advancements in the end-to-end integration of O-RAN Architecture components to meet the needs of early adopters. In addition, new software projects in the area of Service Management and Orchestration (SMO) have been initiated to drive the development of auto-configuration and management of O-RAN elements.
The main use cases delivered in Cherry include:
- Policy based Traffic Steering using the A1 and E2 interfaces
- Automated Monitoring and Health check of selected components using the O1 interface
- Configuration, Fault and Performance Management Services aligned with OAM models and specifications newly approved by O-RAN
- Life Cycle Management Framework of rApps and xApps using SMO
- O-DU Low and High pairwise testing in O-RAN Software Community lab
- Simulators for testing and integration, such as E2, A1, Open Test Framework, and more
“It is gratifying to see the continued momentum of the OSC’s open-source O-RAN implementation,” said Jack Murray, co-chair of the OSC Technical Operating Committee (TOC) and Assistant Vice President of AT&T. “AT&T is proud to have continued its contributions to enable RAN AI/ML through the Near-Real Time RIC implementation, and to provide a platform for software testing and integration.”
“We are glad to see Cherry has made big progress by building on the base of Bronze,” said Chih-Lin I, the Co-Chair of O-RAN Technical Steering Committee. “It not only realizes more 3GPP-defined models, but also brings O-RAN defined interfaces including E2 and A1 closer to commercialization. More ML and AI technologies are implemented in the RIC, RICAPP and NRTRIC projects to push the traffic steering e2e use case forward, which makes it a more intelligent RAN. The newly created SMO project is also worth special mention for the quick momentum that it has gained in contributing to O-RAN automation and management within just 3 months.”
“Nokia continues to be very active in O-RAN and a major contributor to the O-RAN specifications,” said Pasi Toivanen, Head of Edge Cloud Platforms at Nokia. “With the Cherry Release, Nokia is contributing to the Near-Real-Time RIC and the E2 interface to advance RAN programmability, network openness, and the introduction of AI/ML intelligence to the network. The contributions also deliver increased robustness, more xApp framework capabilities and enhanced manageability of RIC platform and xApps.”
“Radisys continues to contribute actively to O-RAN standardization and open source development. In the Cherry release, Radisys enhanced O-DU L2 implementation to support UE attach, and integrated with PHY (O-DU Low) through the FAPI interface to enable end-to-end testing," said Ganesh Shenbagaraman, Head of Integrated Products and Ecosystems at Radisys.
“highstreet technologies substantially contributes to O1/OAM within both O-RAN and OSC,” said Alfons Mittermaier, Managing Director of highstreet technologies. “We expect the disaggregated O-RAN architecture to become a door opener for small and medium sized enterprises and will deploy the Cherry release in a 5G reference network in Berlin.”
“HCL has contributed to the O-RAN Software Community across different Work Groups starting with the Cherry Release,” said Ramesh Sriraman, the Head of Telecom Center of Excellence at HCL. “We Improved Near-Real-Time RIC platform CI/CD deployment, automation, performance & scale; introduced AI/ML intelligence to RAN network via xApps; and contributed the initial implementation of the O-RAN O1 interface in the O-DU. It is a great honor for HCL to develop together with the OSC team.”
To learn more about the O-RAN Software Community Cherry release please read this O-RAN Blog post, and to access the code, check out the O-RAN Software Community website.
The O-RAN Software Community continues to be open to any participants that want to get involved in the creation of software for future RAN – for more details please visit https://www.o-ran.org/software.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 240 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005829/en/
Contact information
O-RAN ALLIANCE PR Contact
Zbynek Dalecky
pr@o-ran.org
O-RAN ALLIANCE e.V.
Buschkauler Weg 27
53347 Alfter/Germany
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
